Thomas R. "Tom" Kline

In more than four decades of practicing personal injury law, Thomas R. Kline has forged an incomparable record of courtroom victories, some with remarkable results against seemingly incredible odds. Described by The Philadelphia Inquirer as "one of the nation's most prominent trial lawyers," Kline has achieved hundreds of seven- and eight-figure jury verdicts and settlements. In 2019 alone he achieved jury verdicts of $41 million, $80 million and $8 billion in medical device cases and a prescription pharmaceutical trial. In 2023, he won a $175 million verdict in a Roundup cancer case and followed that in 2024 with a $2.25 billion verdict in another Roundup trial.

In more than four decades of practicing personal injury law, Thomas R. Kline has forged an incomparable record of courtroom victories, some with remarkable results against seemingly incredible odds. Described by The Philadelphia Inquirer as "one of the nation's most prominent trial lawyers," Kline has achieved hundreds of seven- and eight-figure jury verdicts and settlements. In 2019 alone he achieved jury verdicts of $41 million, $80 million and $8 billion in medical device cases and a prescription pharmaceutical trial. In 2023, he won a $175 million verdict in a Roundup cancer case and followed that in 2024 with a $2.25 billion verdict in another Roundup trial.

In more than four decades of practicing personal injury law, Thomas R. Kline has forged an incomparable record of courtroom victories, some with remarkable results against seemingly incredible odds. Described by The Philadelphia Inquirer as "one of the nation's most prominent trial lawyers," Kline has achieved hundreds of seven- and eight-figure jury verdicts and settlements. In 2019 alone he achieved jury verdicts of $41 million, $80 million and $8 billion in medical device cases and a prescription pharmaceutical trial. In 2023, he won a $175 million verdict in a Roundup cancer case and followed that in 2024 with a $2.25 billion verdict in another Roundup trial.